MRI Data Suggest Simufilam is Not Associated with
Safety Finding Based on Blinded MRI Brain Data at Week 40ARIA is a Known Risk Factor for Anti-Amyloid Antibody DrugsMRI Data Presented at the 16th CTAD...
Source: globenewswire.com
Page 23 - Cassava Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cassava Sciences Today - Breaking & Trending Today
Why Cassava Sciences Stock Surged Today
Cassava Sciences, Inc. SAVA shares are trading higher after the company announced MRI data suggested simufilam is not associated with amyloid-related imaging…
Source: biztoc.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. . Such investors are advised to contact Robert S. Willoughby at...
Source: marketscreener.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). Such...
Source: prnewswire.com
STAT Readout Newsletter: Today's biggest biotech updates
Let's unpack Wegovy's inconsistent results, BrainStorm Cell Therapeutics' FDA withdrawal, and Nkarta's successful pivot.
Source: statnews.com